Connection

Pamela Morris to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications Pamela Morris has written about Clinical Trials as Topic.
Pamela Morris
Connection Strength
0.030
Clinical Trials as Topic
  1. Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.